Urology
Volume 70, Issue 6, Supplement 1 , Pages S22-S26 , December 2007

Is There a Better Way to Biopsy the Prostate? Prospects for a Novel Transrectal Systematic Biopsy Approach

  • Gerald L. Andriole

      Affiliations

    • Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
    • Corresponding Author InformationReprint requests: Gerald L. Andriole, MD, Division of Urologic Surgery, Washington University School of Medicine, 4960 Children’s Place, Campus Box 8242, St. Louis, Missouri 63110.
    • Dr. Andriole is a paid consultant to Aeterna Zentaris, Onconomica, Roche, Solvay, and Viking Medical Systems; is a study investigator partially funded by Antigenics, GlaxoSmithKline, CD Searle, and Zeneca; and has financial interests in Envisioneering and Viking Medical Systems.
    • ,
  • Travis L. Bullock

      Affiliations

    • Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
    • Dr. Bullock has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • Jay S. Belani

      Affiliations

    • Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
    • Dr. Belani has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • Erica Traxel

      Affiliations

    • Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
    • Dr. Traxel has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • Yan Yan

      Affiliations

    • Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
    • Dr. Yan has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • David G. Bostwick

      Affiliations

    • Bostwick Laboratories, Richmond, Virginia, USA
    • Dr. Bostwick is a study investigator for Bioniche, Dendreon, DiagnoCure, Endocare, Genotherapeutics, GlaxoSmithKline, and Health Tronics; and is the founder and majority shareholder in Bostwick Laboratories.
    • ,
  • Peter A. Humphrey

      Affiliations

    • Department of Pathology, Washington University School of Medicine, St. Louis, Missouri, USA
    • Dr. Humphrey has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.

References 

  1. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142:71–75
  2. Stamey TA. Making the most out of six systematic sextant biopsies. Urology. 1995;45:2–12
  3. Presti JC. Prostate biopsy: how many cores are enough?. Urol Oncol. 2003;21:135–140
  4. Rabbani F, Stroumbakis N, Kava BR, et al. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998;159:1247–1250
  5. Presti JC, Chang JJ, Bhargava V, et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000;163:163–167
  6. Presti JC, O’Dowd GJ, Miller MC, et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol. 2003;169:125–129
  7. Makhlouf AA, Krupski TL, Kunkle D, et al. The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy. BJU Int. 2004;93:271–274
  8. San Francisco IF, DeWolf WC, Rosen S, et al. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol. 2003;169:136–140
  9. Sofer M, Savoie M, Kim SS, et al. Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol. 2003;169:153–156
  10. Chan TY, Chan DY, Stutzman KL, et al. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?. J Urol. 2001;166:2181–2184
  11. Brossner C, Bayer G, Madersbacher S, et al. Twelve prostate biopsies detect significant cancer volumes (>0.5 mL). BJU Int. 2000;85:705–707
  12. Rubin MA, Mucci MR, Manley S, et al. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high-grade tumor be predicted preoperatively?. J Urol. 2001;165:114–118
  13. Crawford ED, Wilson SS, Torkko KC, et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int. 2005;96:999–1004
  14. King CR, McNeal JE, Gill H, et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Ocol Biol Phys. 2004;59:386–391
  15. Emiliozzi P, Maymone S, Paterno A, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol. 2004;172:2224–2226
  16. Anast JW, Andriole GL, Bismar TA, et al. Relating biopsy and clinical variable to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?. J Urol. 2004;64:544–550
  17. Andriole GL, Yan Y, Gonzalez FC, et al. 3-Dimensional prostate mapping biopsy (3D-PMB) predicts radical prostatectomy findings. J Urol. 2006;175:534;Abstract 1655
  18. Moran BJ, Braccioforte MH, Conterato DJ. Stereotactic transperineal prostate biopsy with 3-dimensional mapping of malignancy. In: Program/Proceedings of 2006 Prostate Cancer Symposium, ASCO. San Francisco, California: American Society of Clinical Oncology; 2006;p. 122;Abstract 57
  19. Bismar T, Lewis JS, Vollmer RT, et al. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol. 2003;27:432–440
  20. Bostwick DG. Gleason grading of prostatic needle biopsies: correlation with grade in 316 matched prostatectomies. Am J Surg Pathol. 1994;18:796–803
  21. Noguchi M, Stamey TA, McNeal JE, et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol. 2001;166:104–110
  22. Bullock TL, Belani JS, Yan Y, et al. Comparison of biopsy sample weights between a novel bendable biopsy needle versus the industry standard. 2005;Presented at the Annual Meeting of the American Urological Association; May 21 to 26, San Antonio, Texas

PII: S0090-4295(07)01804-3

doi: 10.1016/j.urology.2007.06.1128

Urology
Volume 70, Issue 6, Supplement 1 , Pages S22-S26 , December 2007

Article Tools

* Image Usage & Resolution